Malaria therapy, experimental, and epidemiological studies have shown that erythrocyte
Duffy blood group-negative people, largely of African ancestry, are resistant to erythrocyte …

Duffy was the first blood group mapped to an autosome (chromosome 1) using cytogenetic
studies. Duffy antigens are located on a glycoprotein that can be found on erythrocytes and …

More than one-third of the world's population is exposed to Plasmodium vivax malaria,
mainly in Asia. P. vivax preferentially invades reticulocytes (immature red blood cells) …

The erythrocyte silent Duffy blood group phenotype in Africans is thought to confer
resistance to Plasmodium vivax blood-stage infection. However, recent studies report P …

Currently, there are no reliable RBC invasion assays to guide the discovery of vaccines
against Plasmodium vivax, the most prevalent malaria parasite in Asia and South America …

The nature of the relationship between an antigenic amino acid sequence and its capability
to evoke an immune response is still an unsolved problem. Although experiments indicate …

Background The study of the biology, transmission and pathogenesis of Plasmodium vivax
is hindered due to the lack of a robustly propagating, continuous culture of this parasite. The …

Malaria is caused by multiple different species of protozoan parasites, and interventions in
the pre-elimination phase can lead to drastic changes in the proportion of each species …

The Duffy antigen/receptor for chemokine (DARC) is an erythrocyte receptor for malaria
parasites (Plasmodium vivax and Plasmodium knowlesi) and for chemokines. In contrast to …

Expression of the lymphoendothelial marker membrane mucoprotein podoplanin (podo)
distinguishes endothelial cells of both blood and lymphatic lineages. We have previously …